Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
Sonia Ares‐Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, Jacobo Pardo‐Seco, Olaia Pérez‐Martínez, María‐Teresa Otero‐Barrós, Nuria Súarez‐Gaiche, Rolf Kramer, Jing Jin, Leticia Platero-Alonso, Rosa‐María Alvárez‐Gil, Olga‐María Ces‐Ozores, Victoria Nartallo‐Penas, Susana Mirás‐Carballal, Marta Piñeiro-Sotelo, Alberto Malvar‐Pintos, Juan‐Manuel González‐Pérez, Carmen Rodrı́guez-Tenreiro, Irene Rivero‐Calle, Antonio Salas, Carmen Durán‐Parrondo, Federico Martinón‐Torres
Topics & Concepts
MedicinePalivizumabPediatricsRespiratory tract infectionsPoisson regressionPopulationPublic healthBronchiolitisEmergency medicineRespiratory systemEnvironmental healthInternal medicineNursingRespiratory viral infections researchCOVID-19 Clinical Research StudiesVirus-based gene therapy research